BRIEF-GSK, Vir Submit EUA Request To FDA For Vir-7831 For Early Treatment Of COVID-19
March 26 (Reuters) - GSK:* GSK AND VIR BIOTECHNOLOGY ANNOUNCE SUBMISSION OF EMERGENCY USE AUTHORIZATION REQUEST TO FDA FOR VIR-7831 FOR EARLY TREATMENT OF ...
March 26 (Reuters) - GSK:* GSK AND VIR BIOTECHNOLOGY ANNOUNCE SUBMISSION OF EMERGENCY USE AUTHORIZATION REQUEST TO FDA FOR VIR-7831 FOR EARLY TREATMENT OF ...